Pulse monitoring post-stroke could help prevent a second stroke
by Bruce Sylvester – Researchers report that routinely monitoring the pulse of anyone who has had a stroke could detect irregular heartbeat, a major cause of second stroke…. read more.
by Bruce Sylvester – Researchers report that routinely monitoring the pulse of anyone who has had a stroke could detect irregular heartbeat, a major cause of second stroke…. read more.
Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials. ‘The company should be encouraged by the drug’s demonstrated efficacy in mild… read more.
by Bruce Sylvester – Treatment with tadalafil or sidenafil appears to improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to research published in… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be… read more.
This year saw the first of an exciting new style of conference. The Urology QT Conference was based on a ‘Question Time’ format that encouraged lively debate and… read more.
by Bruce Sylvester – Researchers report that administering blood pressure lowering drugs to patients in the first 48 hours after a stroke does not lower the risk of… read more.
by Bruce Sylvester – Following a first ischemic stroke, patients who keep their blood pressure well controlled appear to halve their risk of a second stroke, researchers reported… read more.
Little evidence other complementary or alternative therapies work. A new guideline from the American Academy of Neurology suggests that there is little evidence that most complementary or alternative… read more.
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to… read more.
by Bruce Sylvester – An investigative drug could offer the first safe and effective treatment for psychotic symptoms that affect about half of people with Parkinson’s disease, researchers… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.